Defunct Company
Total Trials
14
As Lead Sponsor
13
As Collaborator
1
Total Enrollment
981
NCT01440166
Safety, Tolerability, and Pharmacokinetic Study of CAT-1004 in Healthy Adult Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 30, 2011
Completion: Jan 31, 2012
NCT01511900
A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes
Start: Dec 31, 2011
Completion: Apr 30, 2012
NCT01670773
A Study of CAT-1004 Biomarkers in Healthy Subjects
Start: Aug 31, 2012
Completion: Oct 31, 2012
NCT01725594
A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003
Start: Nov 30, 2012
Completion: May 31, 2013
NCT01912560
Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia
Phase: Phase 2
Start: Jul 31, 2013
Completion: Dec 31, 2013
NCT01968720
Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
Start: Oct 31, 2013
Completion: Apr 30, 2014
NCT02098278
Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia
Start: Mar 31, 2014
Completion: Apr 30, 2015
NCT02374047
A 2-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CAT-2054 in Healthy Subjects
Start: Jan 31, 2015
Completion: Jul 31, 2015
NCT02608697
A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia
Start: Oct 31, 2015
Completion: Jun 30, 2016
NCT02439216
Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy
Phase: Phase 1/2
Start: Apr 30, 2016
Completion: Aug 31, 2019
NCT03680365
Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families
Phase: N/A
Role: Collaborator
Start: Sep 20, 2018
Completion: Mar 15, 2019
NCT03703882
Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy
Phase: Phase 3
Start: Oct 2, 2018
Completion: Sep 22, 2020
NCT03917719
An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy
Start: Mar 14, 2019
Completion: Oct 26, 2020
NCT04543370
Study of Edasalonexent With Midazolam and Deflazacort in Healthy Subjects
Start: Aug 8, 2020
Completion: Oct 1, 2020